104 related articles for article (PubMed ID: 25572590)
1. XAGE-1b cancer/testis antigen is a potential target for immunotherapy in prostate cancer.
Xie C; Wang G
Urol Int; 2015; 94(3):354-62. PubMed ID: 25572590
[TBL] [Abstract][Full Text] [Related]
2. A dendritic cell-based tumour vaccine for lung cancer: full-length XAGE-1b protein-pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro.
Zhou Q; Guo AL; Xu CR; An SJ; Wang Z; Yang SQ; Wu YL
Clin Exp Immunol; 2008 Sep; 153(3):392-400. PubMed ID: 18803763
[TBL] [Abstract][Full Text] [Related]
3. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
[TBL] [Abstract][Full Text] [Related]
4. Promoting effects on the proliferation and metastasis of ACC tumor cell with XAGE-1b overexpression.
Zhou B; Li T; Liu Y; Zhu N
Oncol Rep; 2013 Nov; 30(5):2323-35. PubMed ID: 24008415
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients.
Ohue Y; Eikawa S; Okazaki N; Mizote Y; Isobe M; Uenaka A; Fukuda M; Old LJ; Oka M; Nakayama E
Int J Cancer; 2012 Sep; 131(5):E649-58. PubMed ID: 22109656
[TBL] [Abstract][Full Text] [Related]
6. Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
Saito K; Nakayama E; Valmori D
PLoS One; 2016; 11(3):e0150623. PubMed ID: 26937656
[TBL] [Abstract][Full Text] [Related]
7. Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors.
Sato S; Noguchi Y; Ohara N; Uenaka A; Shimono M; Nakagawa K; Koizumi F; Ishida T; Yoshino T; Shiratori Y; Nakayama E
Cancer Immun; 2007 Mar; 7():5. PubMed ID: 17335148
[TBL] [Abstract][Full Text] [Related]
8. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma.
Ali Eldib AM; Ono T; Shimono M; Kaneko M; Nakagawa K; Tanaka R; Noguchi Y; Nakayama E
Int J Cancer; 2004 Feb; 108(4):558-63. PubMed ID: 14696120
[TBL] [Abstract][Full Text] [Related]
9. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis.
Zendman AJ; van Kraats AA; den Hollander AI; Weidle UH; Ruiter DJ; van Muijen GN
Int J Cancer; 2002 Jan; 97(2):195-204. PubMed ID: 11774264
[TBL] [Abstract][Full Text] [Related]
10. Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.
Mori M; Funakoshi T; Kameyama K; Kawakami Y; Sato E; Nakayama E; Amagai M; Tanese K
J Dermatol; 2017 Jun; 44(6):671-680. PubMed ID: 28105694
[TBL] [Abstract][Full Text] [Related]
11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
12. Characterization of overlapping XAGE-1 transcripts encoding a cancer testis antigen expressed in lung, breast, and other types of cancers.
Egland KA; Kumar V; Duray P; Pastan I
Mol Cancer Ther; 2002 May; 1(7):441-50. PubMed ID: 12479262
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic XAGE-1b-specific immunity in patients with lung adenocarcinoma.
Talebian Yazdi M; Loof NM; Franken KL; Taube C; Oostendorp J; Hiemstra PS; Welters MJ; van der Burg SH
Cancer Immunol Immunother; 2015 Sep; 64(9):1109-21. PubMed ID: 26025564
[TBL] [Abstract][Full Text] [Related]
14. [Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].
Prikler L; Scandella E; Men Y; Engeler DS; Diener PA; Gillessen S; Ludewig B; Schmid HP
Aktuelle Urol; 2004 Aug; 35(4):326-30. PubMed ID: 15459874
[TBL] [Abstract][Full Text] [Related]
15. Computational prediction of vaccine potential epitopes and 3-dimensional structure of XAGE-1b for non-small cell lung cancer immunotherapy.
Tarek MM; Shafei AE; Ali MA; Mansour MM
Biomed J; 2018 Apr; 41(2):118-128. PubMed ID: 29866600
[TBL] [Abstract][Full Text] [Related]
16. [Association of XAGE-1b gene expression with clinical characteristics of non-small cell lung cancer].
Zhou Q; Guo AL; An SJ; Xu CR; Yang SQ; Wu YL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):966-8. PubMed ID: 17666327
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of immunoglobulin γ and κ chains influence humoral immunity to the cancer-testis antigen XAGE-1b (GAGED2a) in patients with non-small cell lung cancer.
Pandey JP; Namboodiri AM; Ohue Y; Oka M; Nakayama E
Clin Exp Immunol; 2014 Apr; 176(1):78-83. PubMed ID: 24304136
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells transfected with interleukin-12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo.
Zhang S; Zeng G; Wilkes DS; Reed GE; McGarry RC; Eble JN; Cheng L
Prostate; 2003 Jun; 55(4):292-8. PubMed ID: 12712408
[TBL] [Abstract][Full Text] [Related]
19. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.
Shimono M; Uenaka A; Noguchi Y; Sato S; Okumura H; Nakagawa K; Kiura K; Tanimoto M; Nakayama E
Int J Oncol; 2007 Apr; 30(4):835-40. PubMed ID: 17332921
[TBL] [Abstract][Full Text] [Related]
20. Activation of human cancer/testis antigen gene, XAGE-1, in tumor cells is correlated with CpG island hypomethylation.
Lim JH; Kim SP; Gabrielson E; Park YB; Park JW; Kwon TK
Int J Cancer; 2005 Aug; 116(2):200-6. PubMed ID: 15800911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
